Do serum androgens influence blastocysts ploidy in karyotypically normal women?

References

• Battaglia DE, Goodwin P, Klein NA, Soules MR. 1996. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Human Reprod. Oxford, England. 11(10):2217–2222. eng.
   PubMed Web of Science ®Google Scholar
• Bonser J, Walker J, Purohit A, Reed MJ, Potter BV, Willis DS, Franks S, Mason HD. 2000. Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production. J Endocrinol. 167(3):465–471. eng.
   PubMed Web of Science ®Google Scholar
• Brezina PR, Anchan R, Kearns WG. 2016. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? J Assist Reprod Genet. 33(7):823–832. en.
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. 2006. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 12(6):685–718. en.
   PubMed Web of Science ®Google Scholar
• Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, Nagy ZP, Ubaldi FM. 2014. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Human Reprod. 29(6):1173–1181. en.
   PubMed Web of Science ®Google Scholar
• Dickerson EH, Cho LW, Maguiness SD, Killick SL, Robinson J, Atkin SL. 2010. Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-PCOS women undergoing IVF. Human Reprod. 25(2):504–509. en.
   PubMed Web of Science ®Google Scholar
• Ferrario M, Secomandi R, Cappato M, Galbignani E, Frigerio L, Arnoldi M, Fusi FM. 2015. Ovarian and adrenal androgens may be useful markers to predict oocyte competence and embryo development in older women. Gynecological Endocrinol. 31(2):125–130. en.
   PubMed Web of Science ®Google Scholar
• Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, Scott RT. 2014. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 101(3):656–663.e651. en.
   PubMed Web of Science ®Google Scholar
• García-Ferreyra J, Hilario R, Dueñas J. 2018. High percentages of embryos with 21, 18 or 13 trisomy are related to advanced paternal age in donor egg cycles. JBRA Assisted Reprod. 22(1):26–34. en.
   PubMed Web of Science ®Google Scholar
• Gleicher N, McCulloh DH, Kushnir VA, Ganguly N, Barad DH, Goldman KN, Kushnir MM, Albertini DF, Grifo JA. 2015. Is there an androgen level threshold for aneuploidy risk in infertile women? Reprod Biol Endocrinol. 13(1):38. en.
   Google Scholar
• Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH. 2009. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol. 7(1):108. en.
   PubMedGoogle Scholar
• Gleicher N, Weghofer A, Barad DH. 2010. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol. 8(1):140. en.
   PubMedGoogle Scholar
• González-Comadran M, Durán M, Solà I, Fábregues F, Carreras R, Checa MA. 2012. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis. Reprod Biomed Online. 25(5):450–459. en.
   PubMed Web of Science ®Google Scholar
• Grati FR, Gallazzi G, Branca L, Maggi F, Simoni G, Yaron Y. 2018. An evidence-based scoring system for prioritizing mosaic aneuploid embryos following preimplantation genetic screening. Reprod Biomed Online. 36(4):442–449. en.
   PubMed Web of Science ®Google Scholar
• Harper JC, Harton G. 2010. The use of arrays in preimplantation genetic diagnosis and screening. Fertil Steril. 94(4):1173–1177. en
   PubMed Web of Science ®Google Scholar
• Jiang X, Yan J, Sheng Y, Sun M, Cui L, Chen Z-J. 2018. Low anti-Müllerian hormone concentration is associated with increased risk of embryonic aneuploidy in women of advanced age. Reprod Biomed Online. 37(2):178–183. en.
   Web of Science ®Google Scholar
• Katz-Jaffe MG, Surrey ES, Minjarez DA, Gustofson RL, Stevens JM, Schoolcraft WB. 2013. Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstet Gynecol. 121(1):71–77. eng.
   PubMed Web of Science ®Google Scholar
• Kuliev A, Verlinsky Y. 2004. Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosis. Hum Reprod Update. 10(5):401–407. en.
   PubMed Web of Science ®Google Scholar
• La Marca A, Minasi MG, Sighinolfi G, Greco P, Argento C, Grisendi V, Fiorentino F, Greco E. 2017. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril. 108(5):777–783.e772. en.
   PubMed Web of Science ®Google Scholar
• La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, Xella S, Marsella T, Tagliasacchi D, D’Amico R, et al. 2011. Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed Online. 22(4):341–349. en
   PubMed Web of Science ®Google Scholar
• Labrie F, Bélanger A, Cusan L, Gomez J-L, Candas B. 1997. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clinl Endocrinol Metabol. 82(8):2396–2402. en.
   PubMed Web of Science ®Google Scholar
• Lehmann P, Vélez MP, Saumet J, Lapensée L, Jamal W, Bissonnette F, Phillips S, Kadoch I-J. 2014. Anti-Müllerian Hormone (AMH): a reliable biomarker of oocyte quality in IVF. J Assist Reprod Genet. 31(4):493–498. en.
   PubMed Web of Science ®Google Scholar
• Lim AS, Tsakok MF. 1997. Age-related decline in fertility: a link to degenerative oocytes? Fertil Steril. 68(2):265–271. eng.
   PubMed Web of Science ®Google Scholar
• Liss J, Pastuszek E, Pukszta S, Hoffmann E, Kuczynski W, Lukaszuk A, Lukaszuk K. 2018. Effect of next-generation sequencing in preimplantation genetic testing on live birth ratio. Reprod Fertil Dev. 30(12):1720–1727. en.
   PubMed Web of Science ®Google Scholar
• Lukaszuk K, Liss J, Lukaszuk M, Maj B. 2005. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization–embryo transfer cycles. Fertil Steril. 83(5):1372–1376. en.
   PubMed Web of Science ®Google Scholar
• Mateo S, Vidal F, Coll L, Veiga A, Boada M. 2017. Chromosomal analysis of blastocyst derived from monopronucleated ICSI zygotes: approach by double trophectoderm biopsy. JBRA Assisted Reprod. 21(3):203–207. en
   PubMed Web of Science ®Google Scholar
• Maxwell SM, Grifo JA. 2018. Should every embryo undergo preimplantation genetic testing for aneuploidy? A review of the modern approach to in vitro fertilization. Best Pract Res Clin Obstet Gynaecol. 53:38–47. eng
   PubMed Web of Science ®Google Scholar
• Minasi MG, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F, Spinella F, Fiorentino F, Varricchio MT, Greco E. 2016. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Human Reprod. 31(10):2245–2254. en.
   PubMed Web of Science ®Google Scholar
• Munné S. 2018. Status of preimplantation genetic testing and embryo selection. Reprod Biomed Online. 37(4):393–396. eng.
   PubMed Web of Science ®Google Scholar
• Munné S, Alikani M, Ribustello L, Colls P, Martínez-Ortiz PA, Referring Physician G, McCulloh DH. 2017. Euploidy rates in donor egg cycles significantly differ between fertility centers. Human Reprod. 32(4):743–749. en.
   PubMed Web of Science ®Google Scholar
• Palmerola KL, Vitez SF, Amrane S, Fischer CP, Forman EJ. 2019. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A). J Assist Reprod Genet. 36(1):153–157. eng.
   PubMed Web of Science ®Google Scholar
• Pastuszek E, Lukaszuk A, Kunicki M, Mockun J, Kloss G, Malinowska I, Czyzyk A, Meczekalski B, Lukaszuk K. 2017. New AMH assay allows rapid point of care measurements of ovarian reserve. Gynecological Endocrinol. 33(8):638–643. en.
   PubMed Web of Science ®Google Scholar
• Pellestor F, Andréo B, Arnal F, Humeau C, Demaille J. 2003. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet. 112(2):195–203. eng.
   PubMed Web of Science ®Google Scholar
• PGDIS Position Statement on Chromosome Mosaicism and Preimplantation Aneuploidy Testing at the Blastocyst Stage. 2016. PGDIS Newsletter. en.
   Google Scholar
• Rotterdam EA-SPCWG. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 81(1):19–25. eng.
   Web of Science ®Google Scholar
• Sathyapalan T, Dickerson EH, Maguiness SM, Robinson J, Dakroury YHZ, Atkin SL. 2017. Androstenedione and testosterone levels correlate with in vitro fertilization rates in insulin-resistant women. BMJ Open Diabetes Res Care. 5(1):e000387. en.
   PubMedGoogle Scholar
• Scott RT, Ferry K, Su J, Tao X, Scott K, Treff NR. 2012. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril. 97(4):870–875. eng.
   PubMed Web of Science ®Google Scholar
• Spinella F, Fiorentino F, Biricik A, Bono S, Ruberti A, Cotroneo E, Baldi M, Cursio E, Minasi MG, Greco E. 2018. Extent of chromosomal mosaicism influences the clinical outcome of in vitro fertilization treatments. Fertil Steril. 109(1):77–83. en.
   PubMed Web of Science ®Google Scholar
• Treff NR, Tao X, Ferry KM, Su J, Taylor D, Scott RT. 2012. Development and validation of an accurate quantitative real-time polymerase chain reaction-based assay for human blastocyst comprehensive chromosomal aneuploidy screening. Fertil Steril. 97(4):819–824. eng.
   PubMed Web of Science ®Google Scholar
• Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. 1998. Androgens stimulate early stages of follicular growth in the primate ovary. J Clinl Invest. 101(12):2622–2629. en.
   PubMed Web of Science ®Google Scholar
• Victor AR, Tyndall JC, Brake AJ, Lepkowsky LT, Murphy AE, Griffin DK, McCoy RC, Barnes FL, Zouves CG, Viotti M. 2019. One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies. Fertil Steril. 111(2):280–293. eng.
   PubMed Web of Science ®Google Scholar
• Weghofer A, Munne S, Chen S, Barad D, Gleicher N. 2007. Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril. 88(4):900–905. en.
   PubMed Web of Science ®Google Scholar
• Weil S, Vendola K, Zhou J, Bondy CA. 1999. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clinl Endocrinol Metabol. 84(8):2951–2956. en.
   PubMed Web of Science ®Google Scholar
• Wells D, Kaur K, Grifo J, Glassner M, Taylor JC, Fragouli E, Munne S. 2014. Clinical utilisation of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantation. J Med Genet. 51(8):553–562. eng.
   PubMed Web of Science ®Google Scholar
• Yeung T, Chai J, Li R, Lee V, Ho P, Ng E. 2016. A double‐blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders. BJOG: Int J Obstetrics Gynaecology. 123(7):1097–1105. en.
   PubMed Web of Science ®Google Scholar